A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...
The 340B drug pricing plan is meant to help low-income patients. It needs better oversight in this state.
Community health centers that primarily serve low-income patients fear Gov. Bob Ferguson's proposed supplemental budget will hamper their ability to pa ...
For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...
The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.
Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...
The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...
On January 15, 2026, President Trump released a one-page health policy framework. Among other things, the document includes calls for ...
Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...
Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial ...
The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...
The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results